Clinical trial
A Phase II Trial of Poly ICLC in Patients With Recurrent Anaplastic Glioma
NCT00058123 is registered in ClinicalTrials.gov with Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Trial of Poly ICLC in Patients With Recurrent Anaplastic Glioma
- Lead sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 7, 2003
- Completion date
- January 2, 2009
- Enrollment
- 55 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
brain and central nervous system tumors